Novartis extends collaboration with MorphoSys in biologics

Novartis AG has extended its three-year-old research collaboration with the German biotechnology company, MorphoSys AG, by 10 years in order to increase its involvement in developing therapeutic antibodies, which is MorphoSys’s specialty.